Skip to main content
SpringerLink
Log in

Continuous glucose monitoring in the patients with diabetic nephropathy

  • Published:
Journal of Shanghai Jiaotong University (Science) Aims and scope Submit manuscript

Abstract

The aim of this study was to compare the difference of blood glucose (BG) fluctuation in the patients of type-2 diabetes mellitus (DM-2) with and without clinical diagnosed diabetic nephropathy (DN) by the continuous glucose monitoring system (CGMS). Thirty DM-2 patients with clinical diagnosed DN and fifteen DM-2 patients without complication underwent continuous glucose monitoring for 3 days (72 h) by CGMS. The difference of daily glucose fluctuation in both groups was compared by the parameter of CGMS. The 24-h mean blood glucose (MBG), minimal BG (MIN-BG), area under curve of BG over 7.8 (AUC7.8), percentage of time of BG over 7.8 (PT7.8), area under curve of BG over 11.1 (AUC11.1), percentage of time of BG over 11.1 (PT11.1), as well as mean of daily difference (MODD) were significantly increased in the group of DN, compared with those in the group of DM-2 without complication (all statistic probability P <0.05). No statistical significance of mean amplitude of glycaemic excursion (MAGE) was found. In the group of DN, MBG, standard deviation of blood glucose (SDBG), large amplitude of glycaemic excursion (LAGE), AUC7.8, PT7.8, AUC11.1, PT11.1, MAGE and MODD were (10.7±1.9)mmol/L, (2.5±1.3)mmol/L, (9.2±3.9)mmol/L, 3.2±1.7, (81±18)%, 1.2±1.0, (42±24)%, (5.8±2.5)mmol/L and (2.6±1.5)mmol/L, respectively. The study showed that the BG level of the patients with DN fluctuated throughout the day. MBG of the patients with DN was higher than that of the patients of DM-2 without complications, with the characteristics of long-lasting high BG period, dramatic instability during the day and especially high postprandial blood glucose. CGMS is a useful tool for physicians to know the details of the change of BG in the patients with DN.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Similar content being viewed by others

References

  1. Song M, Alexander C M, Mavros P, et al. Use of the UKPDS outcomes model to predict all-cause mortality in U.S. adults with type-2 diabetes mellitus: Comparison of predicted versus observed mortality [J]. Diabetes Research and Clinical Practice, 2011, 91(1): 121–126.

    Article  Google Scholar 

  2. Kaufman F R, Gibson L C, Havalvorson M, et al. A pilot study of the continuous glucose monitoring system: Clinical decisions and glycemic control after its use in pediatric type 1 diabetic subjects [J]. Diabetes Care, 2001, 24(12): 2034.

    Article  Google Scholar 

  3. American Diabetes Association. Standards of medical care in diabetes [J]. Diabetes Care, 2004, 27(S1):15–35.

    Google Scholar 

  4. Bonakdaran S, Rajabian R. Prevalence and extent of glycemic excursions in well-controlled patients with type 2 diabetes mellitus using continuous glucosemonitoring system [J]. Indian Journal of Medical Science, 2009, 63(2): 66–71.

    Article  Google Scholar 

  5. Rimondi F, Banin P, Gamberini M R, et al. The continuous glucose monitoring system (CGMS) in patients with beta-thalassemia major and impaired glucose homeostasis: Preliminary results [J]. Pediatric Endocrinology Reviews, 2008, 6(S1): 190–192.

    Google Scholar 

  6. Derosa G, Salvadeo S A, Mereu R, et al. Continuous glucose monitoring system in free-living healthy subjects: Results from a pilot study [J]. Diabetes Technology & Therapeutics, 2009, 11(3): 159–169.

    Article  Google Scholar 

  7. Woredekal Y. Early detection and treatment of diabetic nephropathy [J]. Pediatric Endocrinology Reviews, 2008, 5(S4): 999–1004.

    Google Scholar 

  8. Zhou J, Li H, Ran X, et al. Reference values for continuous glucose monitoring in Chinese subjects [J]. Diabetes Care, 2009, 32(7): 1188–1193.

    Article  Google Scholar 

  9. Expert Committee on the Diagnosis and Classification of Diabetes Mellitus. Report of the expert committee on the diagnosis and classification of diabetes mellitus [J]. Diabetes Care, 2003, 26(S1): 5–20.

    Google Scholar 

  10. Kidney Disease Outcome Quality Initiative. K/DOQI clinical practice guidelines for chronic kidney disease: Evaluation, classification, and stratification [J]. American Journal of Kidney Diseases, 2002, 39(S2): 1–266.

    Google Scholar 

  11. Mc Carter Rj, Hempe J M, Chalew S A. Mean blood glucose and biological variation have greater influence on HbAlc levels than glucose instability: An analysis of data from the diabetes control and complications trial [J]. Diabetes Care, 2006, 29(2): 352–355.

    Article  Google Scholar 

  12. Del Prato S. In search of normoglycaemia in diabetes: controlling postprandial glucose [J]. International Journal of Obesity and Related Metabolic Disorders, 2002, 26(S3): 9–17.

    Article  Google Scholar 

  13. Coutinho M, Gerstein H C, Wang Y, et al. The relationship between glucose and incident cardiovascular events: A metaregression analysis of published data from 20 studies of 95,783 individuals followed for 12.4 years [J]. Diabetes Care, 1999, 22(2): 233–240.

    Article  Google Scholar 

  14. Weinzimer S A, DE Lucia M C, Boland E A, et al. Analysis of continuous glucose monitoring data from non-diabetic and diabetic children: A tale of two algorithms [J]. Diabetes Technology & Therapeutics, 2003, 5(3): 375–380.

    Article  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Department of Nephrology, the Sixth People’s Hospital Affiliated to Shanghai Jiaotong University, Shanghai, 200233, China

    Feng Wang  (王 锋), Dong-sheng Cheng  (程东生), Nian-song Wang  (汪年松) & Wen-hui Li  (李文卉)

  2. Department of Endocrinology and Metabolism, the Sixth People’s Hospital Affiliated to Shanghai Jiaotong University, Shanghai, 200233, China

    Yu-qian Bao  (包玉倩), Jian Zhou  (周 健) & Wei-ping Jia  (贾伟平)

Authors
  1. Feng Wang  (王 锋)
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Dong-sheng Cheng  (程东生)
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Nian-song Wang  (汪年松)
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Wen-hui Li  (李文卉)
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. Yu-qian Bao  (包玉倩)
    View author publications

    You can also search for this author in PubMed Google Scholar

  6. Jian Zhou  (周 健)
    View author publications

    You can also search for this author in PubMed Google Scholar

  7. Wei-ping Jia  (贾伟平)
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding authors

Correspondence to Nian-song Wang  (汪年松) or Wei-ping Jia  (贾伟平).

Additional information

Foundation item: the Shanghai United Developing Technology Project of Municipal Hospitals (No. SHDC12006101)

Rights and permissions

Reprints and permissions

About this article

Cite this article

Wang, F., Cheng, Ds., Wang, Ns. et al. Continuous glucose monitoring in the patients with diabetic nephropathy. J. Shanghai Jiaotong Univ. (Sci.) 16, 508–512 (2011). https://doi.org/10.1007/s12204-011-1179-3

Download citation

  • Received:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s12204-011-1179-3

Key words

CLC number

Search

Navigation